Table of Contents
Advances in Hepatology
Volume 2015, Article ID 605292, 7 pages
http://dx.doi.org/10.1155/2015/605292
Research Article

The Incidence of Hepatocellular Carcinoma after Balloon-Occluded Retrograde Transvenous Obliteration

1Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Fukuoka 814-0180, Japan
2The Division of Advanced Clinical Research for Viral Hepatitis and Liver Cancer, Fukuoka University Faculty of Medicine, Fukuoka 814-0180, Japan
3Department of Gastroenterology, Murakami Karindoh Hospital, Fukuoka 819-8585, Japan

Received 7 October 2014; Revised 3 March 2015; Accepted 10 March 2015

Academic Editor: Junyong Park

Copyright © 2015 Keiji Yokoyama et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Kanagawa, S. Mima, H. Kouyama, K. Gotoh, T. Uchida, and K. Okuda, “Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration,” Journal of Gastroenterology and Hepatology, vol. 11, no. 1, pp. 51–58, 1996. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Kim, H. Shijo, H. Kokawa et al., “Risk factors for hemorrhage from gastric fundal varices,” Hepatology, vol. 25, no. 2, pp. 307–312, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. H. J. Grossman, V. L. Grossman, and P. S. Bhathal, “The effect of hepatocyte enlargement on the hemodynamic characteristics of the isolated perfused rat liver preparation,” Hepatology, vol. 27, no. 2, pp. 446–451, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. P. S. Bhathal and H. J. Grossman, “Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators,” Journal of Hepatology, vol. 1, no. 4, pp. 325–337, 1985. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Tanaka, K. Hirohashi, S. Kubo, T. Shuto, I. Higaki, and H. Kinoshita, “Preoperative portal vein embolization improves prognosis after right hepatectomy for hepatocellular carcinoma in patients with impaired hepatic function,” British Journal of Surgery, vol. 87, no. 7, pp. 879–882, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Fukuda, S. Hirota, and K. Sugimura, “Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy,” Journal of Vascular and Interventional Radiology, vol. 12, no. 3, pp. 327–336, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Vallet-Pichard, V. Mallet, B. Nalpas et al., “FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest,” Hepatology, vol. 46, no. 1, pp. 32–36, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Yoshida, Y. Shiratori, M. Moriyama et al., “Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan,” Annals of Internal Medicine, vol. 131, no. 3, pp. 174–181, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Ikeda, M. Kobayashi, Y. Kawamura et al., “Stage progression of small hepatocellular carcinoma after radical therapy: comparisons of radiofrequency ablation and surgery using the Markov model,” Liver International, vol. 31, no. 5, pp. 692–699, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Hori, K. Nagata, S. Hasuike et al., “Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation,” Journal of Gastroenterology, vol. 38, no. 10, pp. 977–981, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Komorizono, M. Oketani, K. Sako et al., “Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation,” Cancer, vol. 97, no. 5, pp. 1253–1262, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Iwata, T. Sohda, S. Nishizawa et al., “Postoperative recurrence in hepatocellular carcinoma: comparison between percutaneous ethanol injection and radiofrequency ablation,” Hepatology Research, vol. 36, no. 2, pp. 143–148, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Sherlock, “Viruses and hepatocellular carcinoma,” Gut, vol. 35, no. 6, pp. 828–832, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Saito, S. Inoue, T. Saito et al., “Augmentation effect of postprandial hyperinsulinaemia on growth of human hepatocellular carcinoma,” Gut, vol. 51, no. 1, pp. 100–104, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. H. B. El-Serag, T. Tran, and J. E. Everhart, “Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma,” Gastroenterology, vol. 126, no. 2, pp. 460–468, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. J. A. Davila, R. O. Morgan, Y. Shaib, K. A. McGlynn, and H. B. El-Serag, “Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study,” Gut, vol. 54, no. 4, pp. 533–539, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. A. A. Samani, S. Yakar, D. LeRoith, and P. Brodt, “The role of the IGF system in cancer growth and metastasis: overview and recent insights,” Endocrine Reviews, vol. 28, no. 1, pp. 20–47, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Makuuchi, B. L. Thai, K. Takayasu et al., “Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report,” Surgery, vol. 107, no. 5, pp. 521–527, 1990. View at Google Scholar · View at Scopus
  19. S. Kobayashi, M. Nagino, Y. Yokoyama, Y. Nimura, and M. Sokabe, “Evaluation of hepatic interleukin-6 secretion following portal vein ligation using a minimal surgical stress model,” Journal of Surgical Research, vol. 135, no. 1, pp. 27–33, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. W. E. Naugler and M. Karin, “The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer,” Trends in Molecular Medicine, vol. 14, no. 3, pp. 109–119, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. M. F. Neurath and S. Finotto, “IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer,” Cytokine and Growth Factor Reviews, vol. 22, no. 2, pp. 83–89, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Nakagawa, S. Maeda, H. Yoshida et al., “Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences,” International Journal of Cancer, vol. 125, no. 10, pp. 2264–2269, 2009. View at Publisher · View at Google Scholar · View at Scopus